Tarsus Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Tarsus Pharmaceuticals Inc inventory turnover ratio, the Tarsus Pharmaceuticals Inc 's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 7.6 in the first quarter 2026, a new company high. Average inventory processing period, for the Tarsus Pharmaceuticals Inc in Mar 31 2026 quarter, has decreased to 48 days, compare to 49 days, in the Dec 31 2025 quarter.

Within Healthcare sector 50 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 161 in the fourth quarter 2025, to 348.

TARS Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Tarsus Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

TARS Inventory Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Inventory Growth	69.02 %	66.87 %	34.79 %	76.45 %	-32.98 %
Y / Y Cost of Sales Growth	80.31 %	182.62 %	156.29 %	-	215.05 %
Inventory Turnover Ratio (TTM)	7.6	7.42	5.66	-	6.32
TARS's Total Ranking	# 348	# 161	# 321	# 179	#
Average inventory processing period	48	49	64	-	58
Seq. Inventory Growth	4.57 %	13.97 %	-0.96 %	43.18 %	3.24 %
Seq. Cost of Sales Growth	-32.51 %	67.55 %	-	-	5.79 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 4
Healthcare Sector	# 51
Overall Market	# 348

Inventory Turnover Ratio Statistics
High	Average	Low
7.6	5.19	2.67
(Mar 31 2026)		(Jun 30 2024)

TARS Company Profile >> Back to TARS Efficiency Comparisons >> Compare TARS Inventory Turnover Ratio to its Competitors

Financial Statements
Tarsus Pharmaceuticals Inc 's Inventories	$ 5 Millions	Visit TARS's Balance sheet
Tarsus Pharmaceuticals Inc 's Cost of Revenues TTM	$ 32 Millions	Visit TARS's Income Statement
What are TARS's Sales?		Visit TARS's Sales by Segment

Other Inventory Turnover Ratios
Tarsus Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
TARS's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for TARS's Competitors
Inventory Turnover Ratio for TARS's Suppliers
Inventory Turnover Ratio for TARS's Customers

You may also want to know
TARS's Sales Growth Rates	TARS's Pe Price to earnings ratio	TARS's Receivables Turnover Ratio	TARS's Stock Quote
TARS's Net Income Growth Rates	TARS's Ps Price to Sales ratio	TARS's Sales per Employee	TARS's Asset Turnover Ratio
TARS's Net Margin	TARS's Pb Price to Book ratio	TARS's Financial Strength Ratios	TARS's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2026	Inventories at quarter ending Mar 31 2026
Lucid Diagnostics Inc	18.30	$ 8.295 Millions	$ 0 Millions
Adapthealth Corp	17.66	$ 2,686.512 Millions	$ 152 Millions
Neuronetics Inc	17.04	$ 78.000 Millions	$ 5 Millions
Precipio inc	15.93	$ 14.540 Millions	$ 1 Millions
Rockwell Medical inc	15.34	$ 56.000 Millions	$ 4 Millions
Aurinia Pharmaceuticals Inc	14.12	$ 30.596 Millions	$ 2 Millions
Star Equity Holdings Inc	13.78	$ 106.877 Millions	$ 8 Millions
Natera Inc	13.48	$ 869.958 Millions	$ 65 Millions
Cryo cell International Inc	13.44	$ 7.049 Millions	$ 1 Millions
The Oncology Institute Inc	11.17	$ 211.805 Millions	$ 19 Millions
Genedx Holdings Corp	11.09	$ 135.000 Millions	$ 12 Millions
Infusystem Holdings Inc	10.96	$ 61.593 Millions	$ 6 Millions
Irhythm Holdings Inc	10.94	$ 228.000 Millions	$ 21 Millions
Earth Science Tech Inc	10.81	$ 8.224 Millions	$ 1 Millions
Option Care Health Inc	10.74	$ 4,579.720 Millions	$ 427 Millions
Zevra Therapeutics Inc	10.44	$ 17.034 Millions	$ 2 Millions
Alnylam Pharmaceuticals Inc	10.38	$ 814.503 Millions	$ 78 Millions
Nutriband Inc	10.06	$ 1.291 Millions	$ 0 Millions
Lantheus Holdings Inc	9.75	$ 610.000 Millions	$ 63 Millions
Sotera Health Company	9.58	$ 531.000 Millions	$ 55 Millions
Warby Parker Inc	9.23	$ 415.000 Millions	$ 45 Millions
National Vision Holdings Inc	8.90	$ 833.415 Millions	$ 94 Millions
Myriad Genetics Inc	8.35	$ 248.000 Millions	$ 30 Millions
Pulse Biosciences Inc	8.08	$ 0.909 Millions	$ 0 Millions
Castle Biosciences Inc	7.97	$ 75.178 Millions	$ 9 Millions
Moderna Inc	7.96	$ 1,733.000 Millions	$ 218 Millions
Carlsmed Inc	7.95	$ 12.557 Millions	$ 2 Millions
Inogen Inc	7.80	$ 195.741 Millions	$ 25 Millions
Cardiff Lexington Corporation	7.70	$ 4.159 Millions	$ 1 Millions
Novavax inc	7.67	$ 89.620 Millions	$ 12 Millions

Date modified: 2026-08-29T17:42:36+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.